Canada turmoil, stock-market politics, a scandal in Norway, ballerinas and food, W. B. Yeats, and more.

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a ...

Meanwhile, A new report from the Health Protection Surveillance Centre (HPSC) found that 605 cases of C diff were reported ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

A Novel First-in-Class Microbiome-Restoration Therapy for the Prevention of Recurrence of C. diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.

A Novel First-in-Class Microbiome-Restoration Therapy for the Prevention of Recurrence of C. diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of ...

Additionally, the long data collection period involved changes in treatment models for IBD and C difficile infection, which may have influenced the results. No financial support was reported for ...